Probiotics and children under hemodialysis treatment
Not Applicable
- Conditions
- Pediatric under hemodialysis treatment.Chronic kidney disease (CKD)
- Registration Number
- IRCT20160206026390N11
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Hemodialysis Patients during study period
Two weeks after Discontinue antibiotics
Two weeks after resolving acute inflammatory settings
Two weeks after Discontinue probiotics
Exclusion Criteria
Patients with Chronic Inflammatory Setting like glumerolonephritis or nephrotic syndrome
Patients received antibiotic or under inflammatory setting like polmunary infection or gastroenteritis
Candidate for transplantation
Receiving immuno-suppressive drugs specially steroids
Receiving probiotics for any reason
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total Antioxidant Capacity. Timepoint: before and after intervention. Method of measurement: ELISA.;Nuclear Factor-kappa B. Timepoint: before and after intervention. Method of measurement: ELISA.;Vascular cell adhesion molecule - 1. Timepoint: before and after intervention. Method of measurement: ELISA.
- Secondary Outcome Measures
Name Time Method . Timepoint: . Method of measurement: .;. Timepoint: . Method of measurement: .